Compare VBF & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VBF | FENC |
|---|---|---|
| Founded | 1970 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 258.5M |
| IPO Year | N/A | 2001 |
| Metric | VBF | FENC |
|---|---|---|
| Price | $15.51 | $7.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 45.5K | ★ 156.3K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 5.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $75.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.68 | $4.68 |
| 52 Week High | $16.27 | $9.92 |
| Indicator | VBF | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 48.62 | 44.94 |
| Support Level | $15.25 | $7.50 |
| Resistance Level | $15.53 | $8.00 |
| Average True Range (ATR) | 0.13 | 0.31 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 57.78 | 26.67 |
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.